Concepedia
Statistics
Publications
7
Citations
182
H-Index
Active since
2013
Affiliations
Kaiser Permanente(Current)
Stanford University
California Institute for Regenerative Medicine
Los Angeles Medical Center
C.N. Chang-Halpenny is an author at Kaiser Permanente specializing in medicine, oncology, and prognostic factors analysis.
Publications per year
2013–2017
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer
Michael F. Gensheimer, Julian C. Hong, C.N. Chang-Halpenny et al. · Radiotherapy and Oncology · 2017 · 39 citations · Full text
Medicine, Nuclear Medicine, Oncology +14
Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy
C.N. Chang-Halpenny, Sathima Natarajan, Julie Hwang-Graziano · Gynecologic Oncology · 2013 · 34 citations
Medicine, Gynecology, Oncology +11
Sequential versus “sandwich” sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma
Sharon Lu, C.N. Chang-Halpenny, Julie Hwang-Graziano · Gynecologic Oncology · 2015 · 33 citations
Medicine, Gynecology, Oncology +14
Elderly Patients with Glioblastoma Multiforme Treated with Concurrent Temozolomide and Standard- versus Abbreviated-Course Radiotherapy
C.N. Chang-Halpenny, Jekwon Yeh, W.W. Lien · The Permanente Journal · 2015 · 25 citations
Medicine, Geriatric Medicine, Oncology +16
Early-stage Uterine Pure and Mixed Clear Cell Carcinoma
C.N. Chang-Halpenny, Sathima Natarajan, Julie Hwang-Graziano · American Journal of Clinical Oncology · 2016 · 21 citations
Medicine, Gynecology, Oncology +15
1–5 of 7